Home

Hamilton Lane Incorporated - Class A Common Stock (HLNE)

175.49
+2.89 (1.67%)
NASDAQ · Last Trade: May 28th, 5:51 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close172.60
Open172.62
Bid70.85
Ask194.58
Day's Range171.34 - 176.52
52 Week Range114.85 - 203.72
Volume1,622,200
Market Cap-
PE Ratio (TTM)44.09
EPS (TTM)4.0
Dividend & Yield1.960 (1.12%)
1 Month Average Volume380,816

Chart

About Hamilton Lane Incorporated - Class A Common Stock (HLNE)

Hamilton Lane Inc is a leading investment management firm that specializes in private markets. The company offers a range of services, including advisory, investment management, and market research, tailored to meet the needs of institutional investors and clients seeking to access the private equity and alternative investment landscape. Hamilton Lane leverages its extensive expertise and proprietary technology to provide insights and strategies that help clients navigate complex investment opportunities while aiming to optimize returns and manage risks. The firm is dedicated to enhancing transparency and efficiency in private market investing through innovative solutions and strategic guidance. Read More

News & Press Releases

Earnings Preview: Hamilton Lanebenzinga.com
Via Benzinga · May 28, 2025
HAMILTON LANE INC-CLASS A (NASDAQ:HLNE) – A Strong Contender for Quality Investorschartmill.com
Hamilton Lane (NASDAQ:HLNE) excels as a quality investment with high ROIC, strong cash flow, and steady growth, making it a standout in private markets solutions.
Via Chartmill · May 27, 2025
5 Analysts Assess Hamilton Lane: What You Need To Knowbenzinga.com
Via Benzinga · May 23, 2025
Price Over Earnings Overview: Hamilton Lanebenzinga.com
Via Benzinga · May 9, 2025
Peering Into Hamilton Lane's Recent Short Interestbenzinga.com
Via Benzinga · April 25, 2025
Breaking Down Hamilton Lane: 5 Analysts Share Their Viewsbenzinga.com
Via Benzinga · April 14, 2025
Expert Outlook: Hamilton Lane Through The Eyes Of 8 Analystsbenzinga.com
Via Benzinga · February 5, 2025
How Is The Market Feeling About Hamilton Lane?benzinga.com
Via Benzinga · January 21, 2025
$100 Invested In This Stock 5 Years Ago Would Be Worth This Much Todaybenzinga.com
Via Benzinga · January 13, 2025
If You Invested $100 In This Stock 5 Years Ago, You Would Have This Much Todaybenzinga.com
Via Benzinga · December 27, 2024
6 Analysts Assess Hamilton Lane: What You Need To Knowbenzinga.com
Via Benzinga · March 20, 2025
What's Driving the Market Sentiment Around Hamilton Lane?benzinga.com
Via Benzinga · March 14, 2025
Cosette Pharmaceuticals Announces Acquisition of Mayne Pharma, Transforming Company into a Leader in Women’s Health and Dermatology
Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated, pharmaceutical company, announced today that it has entered into a definitive agreement to acquire all the outstanding shares of Mayne Pharma Group Limited (ASX: Ticker MYX) (Mayne Pharma) at AUD$7.40/share for a total consideration of approximately USD $430 Million. The Boards of Directors of both companies have approved the transaction and Mayne Pharma’s Board of Directors has unanimously recommended that its shareholders vote in favor of the transaction. The transaction is expected to close in the second quarter of 2025.
By Cosette Pharmaceuticals, Inc. · Via Business Wire · February 20, 2025
2025 Industry Shake-Up: Goldman Highlights KKR, Raymond James, Hamilton Lanebenzinga.com
Goldman Sachs predicts winners and losers among alternative asset managers, brokers, and traditional managers in 2025, with bold rating adjustments.
Via Benzinga · January 6, 2025
$100 Invested In Hamilton Lane 5 Years Ago Would Be Worth This Much Todaybenzinga.com
Via Benzinga · December 16, 2024
The Latest Analyst Ratings For Hamilton Lanebenzinga.com
Via Benzinga · December 12, 2024
(HLNE) - Analyzing Hamilton Lane's Short Interestbenzinga.com
Via Benzinga · December 3, 2024
US Stocks Rise Despite China's Trade Fears, Palantir Defies Gravity, Gold Rallies Further: What's Driving Markets Tuesday?benzinga.com
U.S. stocks advanced midday Tuesday, demonstrating resilience despite escalating geopolitical tensions and trade uncertainties between the world’s two largest economies.
Via Benzinga · February 4, 2025
HAMILTON LANE INC-CLASS A (NASDAQ:HLNE) Exhibits Quality Stock Traits. Here's Why.chartmill.com
Why Quality Investors May Find HAMILTON LANE INC-CLASS A (NASDAQ:HLNE) Attractive.
Via Chartmill · November 28, 2024
How Is The Market Feeling About Hamilton Lane?benzinga.com
Via Benzinga · November 12, 2024
Analyst Ratings For Hamilton Lanebenzinga.com
Via Benzinga · November 11, 2024
Earnings Scheduled For February 4, 2025benzinga.com
Via Benzinga · February 4, 2025
Why HAMILTON LANE INC-CLASS A (NASDAQ:HLNE) qualifies as a quality stock.chartmill.com
This article explores why quality investors may have a look at HAMILTON LANE INC-CLASS A (NASDAQ:HLNE)
Via Chartmill · November 5, 2024
Key Takeaways From Hamilton Lane Analyst Ratingsbenzinga.com
Via Benzinga · October 22, 2024
Demystifying Hamilton Lane: Insights From 8 Analyst Reviewsbenzinga.com
Via Benzinga · October 22, 2024